Statistics from Altmetric.com
Two women at the age of 62 and 42 years underwent secundum type atrial septal defect (ASD) closure with the recently introduced ATRIASEPT II device (Cardia Inc, Eagan, Minnesota, USA). ASD closure devices of size 24 mm and 20 mm were implanted without complications. Intracardiac echocardiography demonstrated satisfactory device deployment. The first patient developed atrial fibrillation approximately 6 weeks after the procedure and therefore …
Competing interests None.
Patient consent Obtained.
Provenance and peer review Not commissioned; not externally peer reviewed.
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.